CG
LUNG icon

Cutler Group’s Pulmonx LUNG Stock Holding History

Cutler Group’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-200
Closed -$3K – 4880
2022
Q3 		$3K Hold
200
– – ﹤0.01% 3982
2022
Q2 		$2K Sell
200
-54,249
-100% -$1.12M ﹤0.01% 4309
2022
Q1 		$1.35M Buy
54,449
+35,296
+184% +$912K 0.07% 307
2021
Q4 		$614K Buy
+19,153
New +$700K 0.03% 647

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
KXA
KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return

Cutler Group's LUNG Position: Q4 2022 in Review

Cutler Group sold out of Pulmonx (LUNG) in Q4 2022, closing a stake of 200 shares — an estimated $3K sold.

Cutler Group first reported a position in LUNG in Q4 2021 and held it in 4 quarters. The position peaked at $1.35M in Q1 2022. 116 funds tracked by Wall St. Rank hold LUNG as of Q4 2022.

  • Cutler Group reported no remaining Pulmonx position as of Q4 2022 after selling out during the quarter.
  • Cutler Group sold 200 Pulmonx shares in Q4 2022, an estimated $3K.
  • Cutler Group first reported a position in Pulmonx in Q4 2021 and held it in 4 quarters.
  • Cutler Group's Pulmonx position peaked at $1.35M in Q1 2022.
  • 116 funds tracked by Wall St. Rank held Pulmonx as of Q4 2022.

Based on Cutler Group's 13F filing for Q4 2022, filed 7 Feb 2023.